Scynexis Inc Reports Results For The Quarter Ended In December: Earnings Summary

Scynexis

29/03/2024 13:32

* SCYNEXIS Inc  SCYX.OQ  reported a quarterly adjusted loss
of 39
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -37
cents.  The mean expectation of five analysts for the quarter
was for a loss of 20 cents per share. Wall Street expected
results to range from -22 cents to -17 cents per share.
    * Revenue rose 280.4% to $5.80 million from a year ago;
analysts
expected $1.37 million. 
    * SCYNEXIS Inc's reported EPS for the quarter was a loss
of 39
cents​.
    * The company reported a quarterly loss of $19.59 million.
    * SCYNEXIS Inc shares had fallen by 36.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for SCYNEXIS Inc is
$7.75 
This summary was machine generated from LSEG data March 29 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.20          -0.39          Missed
 Sep. 30 2023      -0.15          -0.04          Beat
 Jun. 30 2023      1.55           2.46           Beat
 Mar. 31 2023      -0.28          -0.71          Missed